Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2012 3
2013 5
2014 5
2015 6
2016 3
2017 5
2018 6
2019 5
2020 7
2021 4
2022 4
2023 9
2024 10
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG; ENVISION Trial Investigators Group. Mathur M, et al. N Engl J Med. 2024 Jan 4;390(1):20-31. doi: 10.1056/NEJMoa2305635. Epub 2023 Nov 2. N Engl J Med. 2024. PMID: 37916620 Free PMC article. Clinical Trial.
Ocular manifestations in IgA nephropathy.
Oo HH, Choy MYD, Arora A, Yeo SC, Ramachandran R, Gupta V, McCluskey P, Agrawal R. Oo HH, et al. Among authors: yeo sc. Surv Ophthalmol. 2023 Mar-Apr;68(2):290-307. doi: 10.1016/j.survophthal.2022.09.004. Epub 2022 Oct 1. Surv Ophthalmol. 2023. PMID: 36191648 Review.
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
Heerspink HJL, Agarwal R, Bakris GL, Cherney DZI, Lam CSP, Neuen BL, Sarafidis PA, Tuttle KR, Wanner C, Brinker MD, Dizayee S, Kolkhof P, Schloemer P, Vesterinen P, Perkovic V; FIND-CKD investigators. Heerspink HJL, et al. Nephrol Dial Transplant. 2025 Feb 4;40(2):308-319. doi: 10.1093/ndt/gfae132. Nephrol Dial Transplant. 2025. PMID: 38858818 Free PMC article.
Complements and Their Role in Systemic Disorders.
Wang SSY, Tang H, Loe MWC, Yeo SC, Javaid MM. Wang SSY, et al. Among authors: yeo sc. Cureus. 2024 Jan 26;16(1):e52991. doi: 10.7759/cureus.52991. eCollection 2024 Jan. Cureus. 2024. PMID: 38406130 Free PMC article. Review.
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial.
Barratt J, Liew A, Yeo SC, Fernström A, Barbour SJ, Sperati CJ, Villanueva R, Wu MJ, Wang D, Borodovsky A, Badri P, Yureneva E, Bhan I, Cattran D; Cemdisiran Phase 2 Study Investigators and Collaborators. Barratt J, et al. Among authors: yeo sc. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):452-462. doi: 10.2215/CJN.0000000000000384. Epub 2024 Jan 15. Clin J Am Soc Nephrol. 2024. PMID: 38214599 Free PMC article. Clinical Trial.
Circadian regulation of breath alcohol concentration.
Rukmini AV, Jos AM, Yeo SC, Lee N, Mo D, Mohapatra L, Karamchedu S, Gooley JJ. Rukmini AV, et al. Among authors: yeo sc. Sleep. 2021 Jun 11;44(6):zsaa270. doi: 10.1093/sleep/zsaa270. Sleep. 2021. PMID: 33305816
New insights into the pathogenesis of IgA nephropathy.
Yeo SC, Cheung CK, Barratt J. Yeo SC, et al. Pediatr Nephrol. 2018 May;33(5):763-777. doi: 10.1007/s00467-017-3699-z. Epub 2017 Jun 17. Pediatr Nephrol. 2018. PMID: 28624979 Free PMC article. Review.
66 results